{"id":258916,"date":"2020-06-22T22:06:54","date_gmt":"2020-06-23T02:06:54","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=258916"},"modified":"2020-06-22T22:10:01","modified_gmt":"2020-06-23T02:10:01","slug":"thailands-covid-19-vaccine-trial-on-monkeys-successful-minister","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/06\/22\/thailands-covid-19-vaccine-trial-on-monkeys-successful-minister\/","title":{"rendered":"Thailand&#8217;s Covid-19 vaccine trial on monkeys successful: minister"},"content":{"rendered":"<div class=\"mceTemp\"><\/div>\n<figure id=\"attachment_258919\" aria-describedby=\"caption-attachment-258919\" style=\"width: 750px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/06\/photo-1521910386014-76fe6b7bade3.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-258919\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/06\/photo-1521910386014-76fe6b7bade3.jpg\" alt=\"macaque monkey\" width=\"750\" height=\"500\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/06\/photo-1521910386014-76fe6b7bade3.jpg 750w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2020\/06\/photo-1521910386014-76fe6b7bade3-300x200.jpg 300w\" sizes=\"auto, (max-width: 750px) 100vw, 750px\" \/><\/a><figcaption id=\"caption-attachment-258919\" class=\"wp-caption-text\">&#8220;The doses of the mRNA candidate vaccine were administered to the monkeys on May 23 by researchers at the National Primate Research Center in Thailand&#8217;s central province of Saraburi,&#8221; said Higher Education, Science, Research and Innovations Minister Suvit Maesincee. &#8220;All the monkeys remained in good health and have developed satisfactory immune responses to the virus.&#8221; (File Photo:<br \/>Nicholas Punter\/Unsplash)<\/figcaption><\/figure>\n<p><strong>BANGKOK<\/strong>\u00a0\u2013 Thailand&#8217;s Ministry of Higher Education, Science, Research and Innovation announced on Monday that the country&#8217;s coronavirus diseases 2019 (Covid-19) vaccine trial has made progress after macaque monkeys which were given the first doses of the candidate vaccine showed satisfactory immune response.<\/p>\n<p>&#8220;The doses of the mRNA candidate vaccine were administered to the monkeys on May 23 by researchers at the National Primate Research Center in Thailand&#8217;s central province of Saraburi,&#8221; said Higher Education, Science, Research and Innovations Minister Suvit Maesincee. &#8220;All the monkeys remained in good health and have developed satisfactory immune responses to the virus.&#8221;<\/p>\n<p>The minister said the second doses were injected again on Monday into the same monkeys.<\/p>\n<p>&#8220;So if the second doses produce good results, the next step would be human trials, in either October or November, to prove safety and efficacy,&#8221; he said.<\/p>\n<p>The minister said he has assigned Dr. Sirirurg Songsivilai, secretary-general of the National Research Council and Dr. Nakorn Premsri, director of National Vaccine Institute to monitor, examine and advise the research team at the National Primate Research Center.<\/p>\n<p>The minister said that Prime Minister Prayut Chan-o-cha has stressed the importance of producing Thailand&#8217;s own Covid-19 vaccines by cooperating with partner countries such as China and the United States to fight Covid-19.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BANGKOK\u00a0\u2013 Thailand&#8217;s Ministry of Higher Education, Science, Research and Innovation announced on Monday that the country&#8217;s coronavirus diseases 2019 (Covid-19) &hellip;<\/p>\n","protected":false},"author":33,"featured_media":258919,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,17],"tags":[],"class_list":["post-258916","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-w","mauthors-xinhua","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/258916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=258916"}],"version-history":[{"count":2,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/258916\/revisions"}],"predecessor-version":[{"id":258920,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/258916\/revisions\/258920"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/258919"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=258916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=258916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=258916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}